COG: CRO Summit Europe
September 16-17, 2025 – Amsterdam, Netherlands
CRO Summit Europe: Insights from Aixial Group’s Managing Director
Aixial Group is proud to announce our participation in the COG: CRO Summit Europe, held on September 16-17, 2025, in Amsterdam, Netherlands. Don’t miss the opportunity to hear insights from our Managing Director, Jonas Möller, as he delivers a presentation on providing efficient CRO solutions for all your trial needs.
We specialise in applying both expertise and technology to deliver well-managed clinical trial solutions across a wide range of therapeutic areas, including oncology, rare diseases, cell and gene therapy, and other speciality therapeutics. Our commitment is to help you keep everything on track and within budget. With a track record of more than 1,600 clinical trials conducted worldwide and over 300 oncology studies completed, Aixial Group stands as a trusted CRO partner with 20+ years of experience supporting sponsors across North America, Europe, and APAC.
Key highlights of our expertise include:
- 100% oncology-experienced team
- 15 years: average experience of our team members in clinical trial delivery
- 306 oncology trials, including solid tumors, hematologic malignancies, rare and orphan indications
- Experience across Phases I–IV, in both adult and pediatric populations
- Products include drug, device, and combinations via various administration routes such as oral, IV, intratumoral, intralesional, etc.
- Global trial locations across APAC, Europe, LATAM, and North America
Join us at COG: CRO Summit Europe to learn how Aixial Group can be your reliable partner in accelerating your clinical development.

How can we support your next project?
Whether you’re looking for a protocol review or a proposal,
simply reach out to us by filling our request for proposal.